MP21-03 CD-70 BLOCKADE AS A NOVEL IMMUNOTHERAPY FOR THE TREATMENT OF CLEAR-CELL RENAL CELL CARCINOMA

INTRODUCTION AND OBJECTIVES:Although normally restricted to activated B and T-cells, CD70 has been shown to be overexpressed in several types of solid tumor types including RCC, specifically the cl...